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Abstract
The Cop9 signalosome complex (CSN) regulates the functional cycle of the major E3 ubiquitin ligase family, the cullin RING
E3 ubiquitin ligases (CRLs). Activated CRLs are covalently modified by the ubiquitin-like protein Nedd8 (neural precursor cell
expressed developmentally down-regulated protein 8). CSN serves an essential role in myriad cellular processes by reversing
this modification through the isopeptidase activity of its CSN5 subunit. CSN5 alone is inactive due to an auto-inhibited
conformation of its catalytic domain. Here we report the molecular basis of CSN5 catalytic domain activation and unravel a
molecular hierarchy in CSN deneddylation activity. The association of CSN5 and CSN6 MPN (for Mpr1/Pad1 N-terminal)
domains activates its isopeptidase activity. The CSN5/CSN6 module, however, is inefficient in CRL deneddylation, indicating
a requirement of further elements in this reaction such as other CSN subunits. A hybrid molecular model of CSN5/CSN6
provides a structural framework to explain these functional observations. Docking this model into a published CSN electron
density map and using distance constraints obtained from cross-linking coupled to mass-spectrometry, we find that the C-
termini of the CSN subunits could form a helical bundle in the centre of the structure. They likely play a key scaffolding role
in the spatial organization of CSN and precise positioning of the dimeric MPN catalytic core.
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Introduction
The ubiquitin-proteasome system is implicated in virtually all
functions of eukaryotic living cells. The covalent attachment of
ubiquitin molecules, ubiquitylation, requires the concerted inter-
vention of the distinct E1, E2 and E3 enzymes. The most
prominent E3 ubiquitin ligase family comprises the cullin RING
E3 ubiquitin ligases (CRLs). CRLs are important regulators of
cellular homeostasis, division, and responses to various cellular
insults [1]. Their significance is further highlighted by the
deregulation of some CRL elements in human diseases and, in
particular, in cancers [2,3].
CRLs are built around a cullin scaffold, which associates with a
substrate-specific adaptor and a RING finger protein [4]. CRL
activity is tightly regulated to ensure the timely and specific
substrate ubiquitylation [1]. The covalent attachment of the
ubiquitin-like (UBL) molecule Nedd8 (neural precursor cell
expressed developmentally down-regulated protein 8) to cullins,
termed neddylation, activates their ubiquitylation activity by
stabilising an activated conformation of the RING subunit [5,6].
The Cop9 signalosome (CSN) is an eight-subunit complex that
deneddylates cullins [7]. Six of its subunits (CSN1 to CSN4,
CSN7, CSN8) contain a PCI (for Proteasome Cop9 eIF3) domain
and two (CSN5/6) contain an MPN (for Mpr1/Pad1 N-terminal)
domain. The PCI subunits serve a scaffolding function and,
especially through CSN2, help recruit the neddylated CRL
substrates [8]. Structurally, the PCI-containing subunits arrange
in a horseshoe-like shape, juxtaposed with the two MPN subunits.
This architecture is strikingly similar to that of the 26S proteasome
lid and the eukaryotic translation initiation factor eIF3
[8,9,10,11,12,13].
Among the CSN MPN-containing subunits, CSN6 lacks a
functional catalytic site and belongs to the MPN2 class [14,15,16].
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In contrast, CSN5, also known as Jun-activatory binding protein 1
(Jab1) carries the catalytically competent MPN+/JAMM (Jab1-
MPN-Mov34) motif [15,17]. As defined in the AMSH (Associated
Molecule with the SH3 domain of STAM)-like protein (AMSH-
LP) [18], the MPN domain of CSN5 contains two insertions,
namely Insertion-1 (Ins-1; residues 97–131 in human CSN5) and
Insertion-2 (Ins-2; residues 197–219 in human CSN5). These
regions usually contribute to the regulation of the isopeptidase
activity. For AMSH-LP, the Ins-1 region plays a role in the
binding and competent positioning of the distal ubiquitin [18].
CSN5 by itself is found in an inactive state and the transition from
this stand-alone auto-inhibited to the active form probably
requires conformational changes of the Ins-1 region [17,19]. This
is reminiscent of Rpn11 and BRCC36 (for BRCA1 (for Breast
Cancer 1)/BRCA2 (for Breast Cancer 2)-Containing Complex
subunit 36) found in the 26S proteasome lid and BRCC36-
containing complexes, respectively, that are also inactive in the
stand-alone form [20]. Recently, the crystal structure of Rpn11/
Rpn8 MPN domains brought important insights into the
dimerisation of an MPN+/JAMM enzyme with an MPN2 subunit
[21,22], pointing towards the mechanism underlying the catalytic
activation of inactive MPN+/JAMM enzymes upon integration in
higher order assemblies.
Although the structural and functional understanding of the
CSN/CRL interplay has significantly grown over the recent years,
important questions concerning the association of the MPN
domains and the regulation of CSN activity remain. Here we
report that CSN6 N-terminal domain containing its MPN domain
can form a stable heterodimer with CSN5 catalytic domain in
vitro. Biophysical and activity measurements indicate that CSN6
MPN domain stimulates CSN5’s isopeptidase activity. Compar-
ison with CSN on synthetic substrates reveals that both CSN and
the dimeric MPN module display robust isopeptidase activity
towards C-terminal Nedd8 derivatives, but that CSN is a more
efficient deneddylase towards Cullin1-Nedd8 than the CSN5/
CSN6 MPN complex. This suggests that the MPN2 subunit would
contribute significantly to the catalytic activity of the human CSN,
but efficient substrate recruitment would require additional
elements such as other CSN subunits. Moreover, we provide a
structural context for these observations, combining X-ray
crystallography, NMR and cross-linking coupled to MS (CX-
MS) derived data and flexible molecular docking to produce a
molecular model of the CSN5/CSN6 MPN heterodimer and re-
interpret the molecular model of CSN (8). This analysis suggests
that a major part of the subunit-subunit interactions in CSN are
mediated by a helical bundle, composed of the C-termini of CSN’s
subunits, further highlighting its structural similarity to the 26S
proteasome lid [23]. Our work indicates that, in addition to the
importance of their MPN domains for catalysis, the C-terminal
regions of CSN5 and of CSN6 contribute to their anchoring and
precise positioning in the CSN assembly.
Experimental Procedures
Protein production
The expression and purification of human CSN5 1–257
fragment, in the WT and mutant forms were performed as
previously described in [19]. The human CSN6 cDNA was
subcloned in pGEX-6P1 vector (Novagen). The CSN6 31–211
fragment was found to be solubly expressed in bacteria and was
selected for further work. The 1–257 and 31–211 fragments of
CSN5 and CSN6, corresponding to their MPN domains together
with N- and C-terminal appendices for CSN5 and a C-terminal
extension for CSN6, as illustrated in Figure 1A, are referred to as
CSN5DC and CSN6DC, respectively, in the rest of the manuscript.
Expression of CSN6DC and its variants was performed in E. coli
BL21pLysS cells (Novagen) in LB or 15NH4Cl-supplemented M9
minimal expression medium, as required for NMR experiments.
Protein expression was carried out overnight at 18uC and the
following purification buffer (20 mM Tris pH 7.5, 150 mM NaCl,
0.01% monothioglycerol) was used throughout the purification. A
standard purification protocol for GST-tagged proteins was used,
including a first glutathione sepharose affinity step, a size exclusion
chromatography step and a second affinity step to remove
contaminating GST from the purified protein. Purified CSN6DC
was concentrated to 8 mg mL21 and stored at 280uC until further
use. Production of pro-Nedd8 from the pOPIN-E-pro-nedd8
vector (from M. Banfield), was carried out following the protocol
described in [24]. Site directed mutagenesis performed in this
work were done with the QuikChange Lightning Site-Directed
mutagenesis kit (Stratagene) and verified by DNA sequencing.
Production and purification procedures for the CSN and Cullin1-
Nedd8/Rbx1 were carried out following the protocols described in
[8].
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were carried
out on a MicroCal ITC200 microcalorimeter (GE Healthcare,
Piscataway, NJ) at 20uC. The protein samples were all buffer
exchanged using PD-10 desalting column (GE Healthcare) into the
ITC buffer (20 mM Na MES pH 6.5, 75 mM NaCl). Protein
concentrations were measured using a NanoDrop 1000 spectro-
photometer (Thermo Scientific, Wilmington, DE), with the
following extinction coefficients: 56,840 M21cm21 and
18,450 M21cm21 for CSN5DC and CSN6DC, respectively. Titra-
tion of CSN5DC (WT and variants; 100 mM) in the cell (200 mL)
was performed by sequential addition of CSN6DC (WT and
variants; 1 mM; 30 injections of 1.8 mL). Integrated raw ITC data
were fitted to a one site nonlinear least squares fit model using the
MicroCal Origin plugin as implemented in Origin 9.1 (Origin
Lab) after the control experiments (titration of the ligand from the
syringe into the buffer) were subtracted.
Fluorescence anisotropy
To obtain quantitative information about the affinity of
CSN5DC to Nedd8, fluorescence anisotropy measurements were
performed at 28uC, using a TECAN safire2 plate reader (Tecan).
The experiments were performed in 20 mM Hepes pH 7.5 and
75 mM NaCl. Alexa Fluor 488 fluorophore (Life Technologies)
was used to label Nedd8 through a standard amine coupling
procedure. The fluorescence was measured using excitation and
emission wavelengths of 495 nm and 519 nm, respectively.
CSN5DC,WT or.R106T at varying concentrations (0–600 mM) was
incubated in the presence of 4 nM Alexa Fluor 488-Nedd8. The
same procedure was followed in the presence of CSN6DC where a
1:1 ratio of CSN5DC/CSN6DC was used to make the complex at
the indicated concentrations. For each data point the measure-
ment was done in triplicates and the recorded data corresponds to
the average anisotropy. The data obtained were plotted and
analysed using the IgorPro software. The Hill Equation was used
for fitting the data in order to be able to deduct an estimate of the
apparent equilibrium dissociation constant (KD) of each complex
between the protein or protein complex and Alexa Fluor 488-
Nedd8. As there exists no evidence of cooperativity, in all cases,
the data were fit with values of cooperativity equal to 1.
Activity Regulation of CSN5 by CSN6
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Figure 1. CSN6DC activates CSN5DC. (A) Studied protein fragments (brown). The MPN domain boundaries are indicated with dotted lines. (B)
Binding of CSN5DC and CSN6DC measured by ITC. Titration experiments were carried out by injecting concentrated CSN6DC solution into
100 mM CSN5 variants. (C) KD values of CSN5
DC/CSN6DC pairs obtained from ITC data. (D) Activity towards Nedd8-AMC. Nedd8-AMC
hydrolysis rate plot versus substrate concentration (200 nM CSN5DC alone; 4 nM CSN5DC/CSN6DC complex; 23 nM CSN), with data fitted using the
Michaelis-Menten equation. Below: Associated kinetic parameters of the Nedd8-AMC cleavage derived from the left plot. In the CSN5DC,R106T and
CSN5DC,WT/CSN6DC experiments, substrate saturation conditions were not reached and kapp values were extracted from linear fitting of the kobs versus
substrate concentration data. (E) Time-course deneddylation of Cullin1-Nedd8/Rbx1 (1 mM) by the CSN (4 nM; Top) or CSN5DC,WT/CSN6
(4 nM; Bottom). Samples from each time point were analysed on Coomassie stained 15% Tris-tricine SDS-PAGE. Quantification of the cullin
deneddylation was carried out. The bands corresponding to Cullin1-Nedd8 and to Cullin1 show doublet that arise from Cullin1 degradation. (F)
Deneddylase activity on the Cullin1-Nedd8/Rbx1. Substrate hydrolysis (1 mM) is shown as a function of time for 4 nM enzyme (CSN, triangle;
CSN5DC,WT/CSN6DC, square). For context, CSN5DC,R106T alone at 900 nM concentration produces less than 30% of deneddylated Cullin1 for 120 min
reaction (data point not shown for clarity). Data information: N.D., not significant; -, parameters not measured; error bars = s.d.; experiments done at
least twice.
doi:10.1371/journal.pone.0105688.g001
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Isopeptidase assays
Activity assays have been carried out on synthetic and
physiological substrates. A synthetic substrate, namely Nedd8-
AMC (Nedd8 protein conjugated to a 7-amino-4-methyl-couma-
rin molecule (AMC); from Boston Biochem.), and one physiolog-
ical substrate (Cullin1-Nedd8/Rbx1) were used to assess the
catalytic activities of different proteins and complexes used in this
study. For the Nedd8-AMC substrate, initial rate measurements
were carried out at 37uC by following the increase of fluorescence
intensity (lexcitation = 380 nm; lemission = 460 nm), in non-binding
surface, flat-bottom, black 384-well plates (Corning), in a volume
of 50 mL (reaction buffer (50 mM Tris-HCl pH 7.5, 50 mM
NaCl)) on a Tecan safire2 plate reader. The following experimen-
tal conditions were used: 0.5 to 6.0 mM Nedd8-AMC in reaction
buffer, 4 nM CSN5DC/CSN6DC binary complex (110 nM
CSN5DC and 200 nM CSN6DC were mixed prior to reaction
and the concentration of the binary complex was calculated using
the value of the apparent KD value determined by ITC), 200 nM
CSN5DC alone or 23 nM CSN. In the case of saturating
concentrations of Nedd8-AMC, initial rate data were fitted to
the Michaelis-Menten equation using least square analysis to
determine kcat and KM in the Prism software (GraphPad). When
saturating concentrations of Nedd8-AMC were not reached, the
value of k2, corresponding to an approximate value of the kcat/KM
ratio was obtained by linear fitting of initial rate data.
Deneddylation assays
The CSN5DC,WT/CSN6DC complex and recombinant CSN,
were diluted to 4 nM in reaction buffer (20 mM Tris-HCl pH 7.5,
50 mM NaCl) and incubated at 37uC in the presence of 1 mM
Cullin1-Nedd8/Rbx1. A time course (0 to 120 minutes) was
recorded for each reaction in independent duplicates. One time
point was performed for CSN5DC,R106T (900 nM) for 2 hours
incubation time. The reactions were stopped in SDS sample buffer
and analysed on Tris-tricine gel stained in Instant Blue solution
(Expedeon, UK). Bands of Cullin-Nedd8/Rbx1were detected and
quantified using Carestream Molecular Imaging instrument
connected to the Gel Logic 2200PRO software (Equilab, White-
stone, NY).
Pro-Nedd8 processing assays
This assay conditions were as follows: reaction buffer (20 mM
Tris-HCl pH 7.5, 50 mM NaCl); 1 mM pro-Nedd8 WT or
variants; CSN5DC (WT or variants), alone or the CSN5DC/
CSN6DC complex was diluted to 900 nM (for CSN5DC alone) or to
4 nM (for the dimer: 110 nM CSN5DC and 200 nM CSN6DC). A
time course at 37uC was performed in independent duplicates for
each reaction. Samples were analysed as described for deneddyla-
tion assays.
Crystallization, data collection and structure
determination
The coordinate and structure factor files have been deposited in
the PDB under the code 4QFT. Purified CSN6DC at 8 mg mL21
was subjected to crystallisation trials using commercial screening
kits. Crystals grown at 18uC, in 0.2 M Tri-Sodium citrate, 0.1 M
Bis-Tris propane pH 6.5 and 20% PEG3350, were harvested,
cryo-protected in the crystallisation solution supplemented with
10% glycerol and flash-frozen in liquid nitrogen. A dataset was
collected at a 1.8 A˚ resolution at ESRF ID29 beamline and
processed using MOSFLM and SCALA from CCP4 suite [25].
The structure was solved by molecular replacement using Phaser
with the chain A of human Rpn8DC (residues 1–187) as the search
model (PDB code 2O95) [26]. The use of human Rpn8 fragment
structure as the search model for molecular replacement is
supported by the fact that (i) the boundaries of the human
CSN6DC, on which we worked, better correspond to those of
human Rpn8 than to those of Drosophila CSN6DC; (ii) the
structure of Drosophila melanogaster CSN6DC that lacks the C-
terminal portion of the MPN domain displays an atypical strand
orientation at its C-terminus; (iii) the crystal structure of the
human Rpn8DC template model is at the highest resolution
(1.95 A˚). The initial model was built by ARP/wARP into the
electron density map [27]. Further refinement procedure was
carried out by alternate cycles of manual rebuilding and
REFMAC refinement. Data collection and refinement statistics
are compiled in Table S1.
NMR
Uniformly 15N-labelled CSN6DC protein samples were dissolved
in 50 mM Tris buffer, 150 mM NaCl (pH adjusted to 6.8) in 90%
H2O/10% D2O. In all experiments, the
1H carrier was centred on
the water resonance and a WATERGATE sequence [28,29] was
incorporated to suppress solvent resonances. CSN6DC assignment.
Spectra were acquired at 298K and pH 6.8, with a 600 mM
CSN6DC protein sample on a 700 MHz Avance Bruker spec-
trometer equipped with triple-resonance (1H, 15N, 13C) z-gradient
cryo-probe (Figure S1A). NMR data were processed using GIFA (v
4.0) [30], and Topspin (v. 2.1). The 3D 1H-15N-NOESY-
heteronuclear single quantum coherence spectroscopy (HSQC)
spectrum was analysed using strip-plots with manual reordering of
the sequential stretches according to the main chain assignment
strategy [31,32,33]. Side chain assignments were carried out using
the 1H-15N-TOCSY-HSQC spectrum. The first two residues Gly-
Pro in the N-terminal tag were not assigned. For the remaining of
the sequence, assignments were obtained for 15N, HN and Ha
atoms (excluding Pro residues, and A71, L89, D101 and H160
residues). The overall assignment completeness for 1HN-15N
resonances was 98% (Tables S2, S3). CSN5DC/CSN6DC complex.
An HSQC spectrum at 308 K was acquired starting from a 15N-
labelled CSN6DC sample at 100 mM (Figure S1B). After addition
of 200 mM unlabelled CSN5DC to the 15N-labelled CSN6DC
sample, another HSQC was recorded (Figure S1B). The
assignments of CSN6DC at 308K were derived from those at
298K, by recording an intermediate CSN6DC HSQC spectrum at
305K.
Protein-protein docking and modelling
CSN5DC and CSN6DC models were treated as rigid bodies and
all six rotational and translational parameters were fully explored
in the ab initio docking program ZDOCK using 6u sampling on
Euler angles. A list of 30 ‘passive’ solvent-accessible residues of
CSN6DC excluded from the interface with CSN5DC derived from
the analysis of non-shifted CSN6DC peaks in HSQC experiments
in the presence of CSN5DC was incorporated in the filtering option
of the ZDOCK procedure (Figure S1B; Table S4). Among the
54,000 models generated, the top 2,000 complexes, ranked
according to ZDOCK were further analyzed. The starting
structures for human CSN5DC and CSN6DC proteins were the
crystal structures solved at 2.6 A˚ and 1.8 A˚ resolution, respective-
ly. Two docking pairs of protein models were used for docking
simulations: (i) the CSN5DC (chain A, PDB code: 4F7O), with Ins-
1 segment (residues 98–132) fitted to the corresponding ubiquitin-
liganded AMSH-LP Ins-1 structure (AMSH-LP structure corre-
sponds to the MPN domain: residues 264–436; PDB code 2ZNV)
using MODELLER9 program, followed by manual fitting (to
avoid steric clash with the C-terminal LRGG residues of ubiquitin
Activity Regulation of CSN5 by CSN6
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from AMSH-LP distal ubiquitin), combined with the 38–191
CSN6 fragment (a4 deletion; referred to as CSN6DC,Da4); and (ii)
the same CSN5DC model with the N- and C-terminal appending
segments removed (residues 2–31 and 232–257; referred to as
CSN5DC,D2–31,D232–257) combined with CSN6DC,Da4 (residues 38–
207). We subsequently filtered and re-ranked the 2000 hits using a
dedicated procedure incorporating additional experimental con-
straints in order to identify the correct docking conformations.
These constraints were derived from mutagenesis and biochemical
data (CSN6 H44, V115 residues and CSN5 E115, Y116, Y120
residues were contributing to the CSN5/CSN6 interface).
Additional information was also incorporated in this filtering
procedure: primary sequence conservation data for both CSN5
and CSN6 calculated using the PAT server (sequence conservation
calculated for each residue in the aligned sequences, by pairwise
comparisons using a BLOSUM62 matrix-derived substitution
probability score and averaged/normalized for each position to
have a 100% value for absolute conservation) [34], total buried
area in the dimer interface (calculated using the NACCESS
program (http://www.bioinf.manchester.ac.uk/naccess), surface
shape complementarity (obtained by SC program [25,35]) and
interface parameters derived from the PISA program [36].
Docking simulations were performed on Intel Linux cluster
platforms. The low frequency normal modes of CSN5DC were
computed with WEBnm@ server [37], providing information on
regions with slow collective motions. The six first non-trivial
modes were analyzed.
CX-MS
Roughly 100 ml of 1.2 mg/ml CSN sample were cross-linked at
1 mM disuccinimidyl suberate d0/d12 (DSS, Creative Molecules
Inc.), followed by tryptic digestion and enrichment for cross-linked
peptides, essentially as described [38]. LC-MS/MS analysis was
carried out on an Orbitrap Elite mass spectrometer (Thermo
Electron, San Jose, CA) and data were searched using xQuest [39]
in iontag mode with a precursor mass tolerance of 10 ppm. For
matching of fragment ions tolerances of 0.2 Da for common-ions
and 0.3 Da for cross-link ions were used. False discovery rates
(FDR) of cross-linked peptides were assigned using xProphet
(version 2.5.2) [40]. Cross-linked peptides were identified with a
delta Score ,0.95 and a linear discriminant (ld) score .25 and
additionally analyzed by visual inspection in order to ensure good
matches of ion series on both cross-linked peptide chains for the
most abundant peaks.
Revisiting the topology of CSN
The starting point of the modelling work was the assembly
model generated by [8]. To the individual subunit models of the
initial CSN model, were substituted updated models of the
following subunits generated by Phyre [41]: CSN1 (modelled on a
partial crystal structure of the Arabidopsis thaliana (At) protein;
PDB code 4LCT; [42]); CSN5 (modelled on the CSN5DC crystal
structure; PDB code 4F7O; [19]); CSN6 (modelled on the
CSN6DC crystal structure; this work); CSN7 (modelled on a
partial crystal structure of the At protein; PDB code 3CHM; [43]);
CSN8 (modelled on the crystal structure of eIF3k; PDB code
1RZ4; [44]). First the CSN5DC/CSN6DC dimer model was placed
in the EM density map and its position further refined using the
CSN5DC-Nedd8/CSN6DC ternary model. The remaining newly
modelled CSN subunits were placed in the density at their
respective positions, as established by [8], leaving an unoccupied
portion in the electron density. Parallel with the 26S proteasome
lid suggested that the C-termini portions of the CSN subunits
might occupy this portion. We therefore manually placed the
modelled C-termini of the CSN subunits in this density, exploiting
inter-subunit cross-links (Table S5). In the last step of modelling, a
Molecular Dynamics Flexible Fitting (MDFF) approach was used
to improve this initial fit and the quality of the final assembly
model [45]. To do so, the various CSN subunits were first rigidly
fitted into the EM map (EMD 2173) [8], using the collage program
in SITUS package [46]. We used the MDFF procedure with
implicit solvent and optimized strength of structural restraints and
steering forces [47], together with additional Ca-Ca Lys distance
restraints to constrain the experimental inter-subunit cross-linked
lysine residues. 5000 cycles of minimization were followed by
100,000 cycles of restrained steered MD. The accuracy of the
model was assessed by local correlation between the model and the
EM map, and by analysis of the Ca-Ca distance between cross-
linked Lys residues.
Results
The MPN domains of CSN5 and CSN6 form a stable
heterodimer
Previous structural studies of the CSN suggested that CSN5 and
CSN6 interact [8,48]. We therefore set out to quantify the
association between the CSN MPN subunits. The association of
the 1–257 and 31–211 domains of CSN5 and CSN6, amenable to
soluble bacterial expression, referred to as CSN5DC and CSN6D,
respectively (Figures 1A, S2) was probed by ITC experiments. The
data revealed a KD of 661 mM for the MPN heterodimer
(Figure 1B,C). Compatible with these findings, significant changes
in the HSQC spectra comprising shifts, intensity changes and
disappearance of peaks were observed when CSN5DC was added
to 15N-uniformly labelled CSN6DC (Figure S1B). Moreover,
binding of CSN6DC to a conformationally-relaxed CSN5DC
variant, in which the residue arginine 106 of the Ins-1 is
substituted by a threonine (CSN5DC,R106T) [19] was probed by
ITC. In this previous structural, biochemical and computational
analysis of CSN5DC, the Ins-1 region was identified as an
important region for the activation state of CSN5DC. More
specifically, in the WT inactive form of CSN5DC, the Ins-1 appears
conformationally constrained and folded back onto the zinc-
binding site. The conformational relaxation of the Ins-1, allowing
an activity gain of the enzyme, was achieved in silico by loss of a
salt bridge between the arginine 106 (R106) and the aspartate 151
(D151) upon substitution of R106 by a threonine, as shown in
molecular dynamics simulations. This was mirrored in vitro by an
activation of the enzyme upon Ins-1 conformational relaxation
resulting from the un-anchoring of Ins-1 from the zinc-binding
site. ITC measurements indicated a comparable affinity between
CSN6DC and the conformationally-relaxed CSN5DC,R106T variant,
to that of CSN5DC,WT/CSN6DC (Figure 1C).
CSN6DC confers increased Nedd8 affinity and
isopeptidase activity to CSN5DC
The CSN catalytic subunit lacks enzymatic activity in a stand-
alone form, due to the auto-inhibitory position of Ins-1 [17,19,48].
We hypothesized that, while CSN5 by itself has a very low affinity
for Nedd8, upon activation by an unknown factor, the Ins-1 region
rearranges to form part of a Nedd8 recruitment site groove.
Interestingly, MPN- subunits of the 26S proteasome lid and of
BRCC36-containing complexes are able to activate their other-
wise inactive catalytic subunits, Rpn11/POH1 and BRCC36,
respectively [20]. Having shown that the N-terminal MPN
domains of CSN5 and CSN6 heterodimerize, we went on to
evaluate the effect of CSN6DC on CSN5DC’s affinity for Nedd8
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and its isopeptidase activity on substrates ranging from protein to a
physiological complex.
First we utilized a fluorescence anisotropy assay to assess the
binding affinity of Alexa Fluor 488-labelled Nedd8 for CSN5DC
variants (Figure S3). Consistent with our hypothesis, CSN5DC,WT
alone displays the weakest affinity for Nedd8 (KD = 320659 mM),
but conformational relaxation of the Ins-1 region in
CSN5DC,R106T increases the affinity to an apparent KD of
202625 mM. Importantly, the CSN5DC,WT/CSN6DC (or
CSN5DC,R106T/CSN6DC) complex has a similar affinity for
Nedd8, with an apparent KD of 179617 mM (or 144622 mM).
Notably, CSN6DC alone does not appear to greatly contribute to
Nedd8 binding (Figure S3A).
Next the catalytic properties of the enzymes were investigated
on Nedd8-AMC (Figure 1D). Consistent with previous data [19],
200 nM CSN5DC,R106T hydrolysed Nedd8-AMC at a detectable
rate, whilst CSN5DC,WT showed no activity. As saturating
concentrations of the substrate were not reached, we used the
available titration data of CSN5DC,R106T to determine a kapp value
of 5766 M21s21 from the linear fitting of the initial rate data. The
CSN5DC,WT/CSN6DC binary complex at a 4 nM concentration,
obtained by mixing 110 nM CSN5DC,WT and 200 nM CSN6DC,
displayed robust catalytic efficiency (kapp value of
596103616103 M21s21), although the activity of CSN5DC,WT/
CSN6DC complex was not saturable at 6 mM substrate concen-
tration and therefore determination of the kcat/KM ratio was not
possible (Figure 1D). For comparison with the data on the binary
complex, we measured the ability of the holo-CSN to hydrolyse
Nedd8-AMC, which showed saturation by the substrate (Fig-
ure 1D). CSN possesses an estimated kcat/KM ratio value of
176103616103 M21s21 towards Nedd8-AMC.
We subsequently studied the hydrolytic activity of CSN and of
the CSN5DC/CSN6DC dimer on the physiological substrate
Cullin1-Nedd8/Rbx1. The holo-CSN was very efficient at
hydrolysing the isopeptide bond between Nedd8 and Cullin1, as
reported in [49] (Figure 1E,F). Within less than 10 minutes, most
of the Cullin1-Nedd8 substrate at 1 mM, was hydrolysed by 4 nM
CSN, as determined by gel shift assay (Figure 1E). Comparatively,
the activity of 4 nM CSN5DC,WT/CSN6DC dimer on 1 mM
Cullin1-Nedd8 is lower, with a modest proportion of the substrate
processed in the same period (Figure 1E,F). For context, the
processing of 1 mM Cullin1-Nedd8 by 900 nM CSN5DC,R106T
alone (i.e. over 200-fold molar excess of enzyme compared to the
CSN5DC/CSN6DC conditions) after 120 min incubation revealed
that the R106T variant alone has a reduced capacity to hydrolyse
Cullin1-Nedd8 compared to the binary CSN5DC,WT/CSN6DC
complex.
These findings may imply that the heterodimer constituted by
the CSN5/CSN6 MPN domains in the stand-alone state possibly
correspond to the minimal catalytic centre, significantly contrib-
uting to the isopeptidase activity of human CSN, but with low
efficiency on a CSN physiological substrate. As CSN displays
significantly higher deneddylase activity than the CSN5/CSN6
MPN complex on a physiological cullin substrate, this could
suggest that the optimal activity of the CSN5/CSN6 MPN
domains would only be revealed in the context of the holo-CSN
complex. These data suggests a hierarchy in the catalytic activity
over the enzymatic system and the substrate type, with the inactive
CSN5DC,WT form, CSN5DC,R106T that has basal activity, the MPN
heterodimer alone that has robust isopeptidase activity on non-
physiological substrates and the CSN5/CSN6 heterodimer in the
context of CSN that recapitulates strong activity on both non-
physiological and physiological substrates.
CSN6DC crystal structure resembles that of Rpn8DC
To gain additional insights into the molecular mechanism of
CSN5 activation by CSN6, the crystal structure of the MPN2 core
fragment was determined by molecular replacement at 1.76 A˚
resolution, using the human Rpn8DC orthologue as the search
model (PDB code 2O95; Table S1). The CSN6DC structure
encompasses the typical MPN domain fold composed of a central
b-sheet made of seven strands decorated by three a-helices and a
small anti-parallel b-sheet in the Ins-1 region. The MPN core is
extended by a C-terminal appendix (residues 192 to 208) that
includes a small helical portion (a4 201 to 207; Figure 2A). The
asymmetric unit contains one CSN6DC molecule, but the
crystallographic 2-fold symmetry operator generates an a-helix
swapping-stabilised dimer, involving the C-terminal a4 helices
(Figure 2A). The MPN domain dimerisation is structurally well
documented, but, until recently, all the MPN dimers identified
were mediated via different interfaces [14]. Interestingly, despite
their sequence conservation (Figure S4A), the homodimeric
organisation observed in human CSN6DC is different from that
in a CSN6 51–187 fragment from Drosophila melanogaster [16],
but identical to the human Rpn8DC and to the budding yeast
Rpn11DC/Rpn8DC heterodimer crystal structures, comprising the
Rpn8 2–178 or 1–176 and Rpn11 2–239 or 1–220 fragments
[21,22,50] (Figure S4 B–G). Human CSN6DC dimer showed high
structural homology with swapped Rpn8DC dimer, as illustrated in
Figure S4B,C,F,G. 304 equivalent Ca atoms were superimposed
with a rmsd of 1.69 A˚ and a sequence identity of 23% using
LSQMAN program [51]. The same comparison of the monomeric
form of human CSN6DC with human Rpn8DC and Drosophila
CSN6DC gave rmsd values of 1.64 A˚ for 153 Ca pairs and 1.35 A˚
for 84 Ca pairs, respectively.
A highly conserved surface of CSN6DC could mediate the
association with CSN5DC
Crystallisation of the human CSN5DC/CSN6DC heterodimer
has so far been unsuccessful, in spite of extensive trials. Therefore,
to characterise further this complex, we probed the association of
CSN5DC and CSN6DC by NMR to help define the regions
responsible for the interaction. Because of the difficulties to
unambiguously ascribe CSN6DC residues affected by CSN5DC
(owing to size and poor solubility of the binary complex), instead
we extracted, through 15N-CSN6DC HSQC experiments, the
residues that were not perturbed upon addition of CSN5DC (20%
of the residues; Table S4). Although not unambiguous, these
NMR restraints were useful in combination with sequence
conservation pattern and crystal packing information to delineate
a CSN6DC surface potentially impacted by the addition of
CSN5DC. The CSN6DC surface engaged in the binding to
CSN5DC most likely corresponds to the region comprised between
the a1/a2 helices, as delineated in Figure 2B with dotted grey line.
Indeed the functional significance of this particular surface is
strengthened by the facts that: (i) it is a highly conserved surface
among CSN6 family members (Figures 2B,S4A) and (ii) it
corresponds to the homodimer interface found in human CSN6DC
and Rpn8DC crystal structures, as well as to the heterodimer
interface found in budding yeast Rpn11DC/Rpn8DC (Figure-
s 2A,S4B,C,F,G) [21,22].
To further validate this interaction surface, we mutated two
CSN6DC residues, H44 to an alanine and V115 to a glutamic acid,
chosen for their high conservation and their positions on the
putative interaction surface, and determined the effect of these
mutations on the association with CSN5DC by ITC and activity
measurements (Figures S4A,2B,C,D). The H44A variant showed a
slight reduction in heterodimerisation compared with the WT
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Figure 2. CSN6DC binds to CSN5DC. (A) Human CSN6DC displays a classical MPN fold. The crystallised fragment of human CSN6 contains an
MPN core (white ribbon), completed by a C-terminal extension (green ribbon). The asymmetric unit contains one molecule (A); the 2-fold
crystallographic symmetry-related one, A9 is shown in beige as a surface. (B) CSN6DC binding to CSN5DC engages a conserved surface. CSN6
sequence conservation is displayed on the molecular surface of CSN6DC with a colour coding blue to red from variable to conserved, respectively, as
calculated with the PAT server [34]. The dotted line corresponds to the surface fingerprint of CSN5DC,D2–31,D232–257 in the docking model of CSN5DC/
CSN6DC. (C) KD values of CSN5
DC/CSN6DC variant pairs obtained from ITC data. (D) Pro-Nedd8 processing by CSN5DC. Time course assay
of pro-Nedd8 (1 mM) processing by CSN5DC,R106T/CSN6DC (top; 4 nM, obtained from mixing 150 nM CSN5DC,R106T and 200 nM CSN6DC), CSN5DC,R106T/
CSN6DC,H44A (middle; 4 nM) CSN5DC,R106T/CSN6DC,V115E (bottom; 4 nM), were analysed on Coomassie stained SDS-PAGE gels. The time course assay
was analysed on Coomassie stained 15% Tris-tricine SDS-PAGE. Quantification of pro-Nedd8 hydrolysis is specified, when possible, at the bottom of
the gel. Quantification of the pro-Nedd8 processing was carried out as detailed in the Material and Methods section. Although CSN5DC,WT in the
presence of CSN6DC displays robust activity on a range of substrates, as illustrated in Figure 1D,E,F, its level remains lower to that of CSN5DC,R106T in
the presence of CSN6DC. For the pro-Nedd8 gel shift assay, as illustrated in this figure, for detection purpose, it was advantageous to use the best
enzymatic system available.
doi:10.1371/journal.pone.0105688.g002
Activity Regulation of CSN5 by CSN6
PLOS ONE | www.plosone.org 7 August 2014 | Volume 9 | Issue 8 | e105688
Figure 3. JAMM/MPN+-MPN2 assembly. (A,B,C) Ins-1 conformation and UBL binding. Residues discussed in the text are shown in stick
mode and the zinc-coordinating residues in purple. Bottom panel: 90u rotated view with respect to the top panel. (A) AMSH-LP MPN Ins-1 bound
to distal ubiquitin. The binding site of AMSH-LP MPN domain to distal ubiquitin (dark blue), as revealed in [18], is represented in beige and in
yellow, for the Ins-1 region. The position 292, noted A292*, in AMSH-LP MPN has been substituted to an alanine. (B) CSN5DC Ins-1 region in the
stand-alone form (orange) and modelled on the basis of AMSH-LP MPN Ins-1 conformation (noted Ins-1*, yellow). The zone
corresponding to the distal ubiquitin binding site in AMSH-LP MPN (in A) is in beige. (C) Rpn11DC Ins-1 region in the context of the Rpn11DC/
Rpn8DC complex. The Rpn11DC Ins-1 region, together with the zone corresponding to the distal ubiquitin binding site in AMSH-LP MPN (in A) are
presented in yellow and beige, respectively. (D,E,F,G) The structures, in ribbon mode, are, unless specified otherwise, coloured as follows: CSN5DC or
CSN5DC,D2–31,D232–257 in orange (N- and C-terminal extensions in green; Ins-1 region in yellow), CSN6DC,Da4 in violet, Nedd8 in magenta. When visible,
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control, whereas the V115E variant showed a significant 5-fold
reduction in binding (Figures 2C,1C). It is noteworthy that,
although the interaction between CSN5DC and CSN6DC was
impaired by the H44A or to a stronger extent by the V115A
substitution, the effect of these variants remains modest (2 to 5-
fold). The interface mediating the CSN5DC/CSN6DC complex
obtained from the molecular docking encompasses 1,430 to 1,695
A˚2, depending on the type of heterodimer chosen. Prediction of
‘hot spot’ residues making a dominant contribution to the binding
free energy is a difficult task. Here the buried surface is sizeable
and could resist a single substitution not targeting a ‘hot spot’,
whilst affecting a topological modification that would decrease the
activation of CSN5DC by the mutated CSN6DC form(s). We
subsequently probed the hydrolytic activity of the CSN5DC,R106T/
CSN6DC H44A or V115E complex on the Nedd8 precursor, pro-
Nedd8. Indeed, our in vitro work suggested that the CSN5DC/
CSN6DC complex is able to process pro-Nedd8. Although CSN5 is
an unlikely factor for pro-Nedd8 processing [52], we have
exploited it as a reaction tool to substitute for Nedd8-AMC
synthetic substrate, in a gel shift assay, where pro-Nedd8
processing was followed by gel quantification of the appearing
Nedd8 band (Figure 2D). Using this pro-Nedd8 gel shift assay, we
showed that the hydrolytic activity of the CSN5DC,R106T/
CSN6DC,H44A or V115E variant complexes was entirely compro-
mised (Figure 2D).
Taken together and in the context of sequence conservation and
of NMR HSQC data, these results suggest an implication of the
residues H44 and V115 in CSN5DC/CSN6DC binding - although
these residues are possibly not located in a interfacial ‘hotspot’ -
and in CSN6DC-mediated activation of CSN5DC, reinforcing the
view that the CSN5/CSN6 MPN heterodimer is likely to involve a
highly conserved surface exploited in other MPN dimers
[21,22,50]. Further structural confirmation of the involvement of
this surface would be required (see Notes from Authors).
Proposed model of the CSN5/CSN6 MPN domain
heterodimer
Having identified a plausible CSN5DC/CSN6DC interaction
interface, we attempted to further explore the assembly of the
CSN5DC/CSN6DC dimer, molecular docking of the CSN5DC/
CSN6DC complex guided by experimental constraints. It is now
well established that the incorporation of a few biochemical and
NMR-derived constraints in docking methods suffices to deter-
mine the structure of a complex to high precision [53].
To help the docking procedure, a complex composed of
CSN5DC, harbouring an AMSH-LP-like Ins-1 conformation and
of Nedd8, was assembled. To do so, we probed the binding of
Nedd8 on CSN5DC and reciprocally, to investigate whether Nedd8
binds to CSN5DC in a mode reminiscent to that of the distal
ubiquitin to the MPN domain of AMSH-LP (or AMSH). The
choice of the interface residues to be analysed was guided by the
structurally characterised AMSH-LP MPN domain/distal ubiqui-
tin association (Figure 3A,B) [18]. Among the two CSN5DC Ins-1
glutamate positions probed (E115, E122), the E122D variant kept
strong processing activity on pro-Nedd8, whilst the E115D one
displayed weak activity (Fig S5A). The importance of F332 in
AMSH-LP for the distal ubiquitin binding prompted us to
evaluate the role of two aromatic residues in CSN5DC Ins-1
region (Y116, Y120) on the hydrolysis of the Nedd8 precursor (Fig
S5A). Additionally, effects of four pro-Nedd8 variants (T9M,
R42D, K48A, V70D) on processing activity were assessed (Fig
S5B). Activity measurement data on the chosen CSN5DC and pro-
Nedd8 variants showed that the CSN5DC, R106T, E115A,
Y116D.or.Y120D variants have compromised pro-Nedd8 processing
activity and that the pro-Nedd8 ones, namely pro-Nedd8T9M,
R42D, K48A or V70D, are important for hydrolysis by CSN5DC,
validating that Nedd8 on CSN5DC probably orient similarly to the
distal ubiquitin and AMSH-LP MPN (and Sst2, the AMSH
homolog in yeast) (Figures 3A,B, S5A,B) [18,54].
To assemble the CSN5DC-Nedd8 complex we then modelled
the CSN5 Ins-1 segment to resemble that of AMSH-LP MPN.
Interestingly, as a result of the modelling procedure, CSN5DC
modelled Ins-1 resembles the conformation of Rpn11DC Ins-1 in
the binary complex with Rpn8DC (Figure 3C). Exploiting the
above detailed finding that CSN5DC and Nedd8 interaction
proceeds through similar surfaces to that of AMSH-LP-distal
ubiquitin’s (Figures 3A,B, S5A,B), a complex composed of
CSN5DC displaying an AMSH-LP-like Ins-1 conformation and
of Nedd8 was assembled and used to probe the association of
CSN5DC and CSN6DC.
Subsequently, molecular docking simulations of the CSN5DC/
CSN6DC dimer were performed by the software ZDOCK followed
by a tailored post-docking filtering strategy. The simulations
resulted in a cluster of similar docking poses with favourable
interfacial metrics and satisfying all our experimental data
(Figures 3D, S6). In the resulting model, CSN5DC and CSN6DC
are placed in a topology that happens to be close to that observed
in the crystallographic human Rpn8DC and human CSN6DC
homodimers (Figures 3D, S4B,C,F,G) [50].
The surfaces engaged in the CSN5DC/CSN6DC,Da4 model are
highly similar to those of the Rpn11DC/Rpn8DC complex
(Figures 3E, S6). However, superimposition of their MPN+/
JAMM subunits revealed that the CSN6DC,Da4 position on
CSN5DC surface in our model is rotated and translated, relative
to the Rpn8DC position on Rpn11DC (Figure 3E). This difference is
the result of the presence of the CSN5-specific N- and C-terminal
helical appendices on each side of the MPN domain (residues 6 to
17 and 235 to 251, respectively). The CSN5 specific N-terminal
extension wraps around its MPN core and C-terminal helix
(Figure 3F) [19]. For CSN5DC and CSN6DC to arrange in a
Rpn11DC/Rpn8DC-like dimer, it would take the CSN5-specific N-
and C-terminal a-helices to unstaple from its MPN core. To
confirm this, docking carried out on a CSN5DC variant lacking the
N- and C-terminal helices (fragment 32–232) yielded top scoring
solutions corresponding to a pose of the Rpn11DC/Rpn8DC
topology (Figures 3G, S6). These helices were shown to be
the CSN6DC H44 and V115 residues and CSN5DC E115, Y116 and Y120 are shown in stick mode. (D) A CSN5/CSN6 model obtained by data-
driven docking. The best CSN5DC-Nedd8/CSN6DC,Da4 pose obtained from the docking procedure is represented. Right panel: 180u rotated view of
left Panel. (E) Topology of CSN5DC/CSN6DC dockingmodel and Rpn11DC/Rpn8DC-like CSN5DC/CSN6DC. The best CSN5DC-Nedd8/CSN6DC,Da4
pose obtained from filtering ZDOCK solutions is represented, as in (D). To this model, the CSN5DC-Nedd8/CSN6DC,Da4 model built following the
Rpn11DC/Rpn8DC structure has been superimposed. The CSN6DC,Da4 structure that is superimposed onto Rpn8DC is shown in pink to distinguish it
from the CSN6DC,Da4 obtained in our docking solution. Right panel: 180u rotated view of left Panel. (F) The N- and C-terminal helices specific to
CSN5DC. The N- and C-terminal helical extensions of CSN5DC are stacked onto the a3 helix and the loop linking the b6–b7 anti-parallel sheet. The
residues involved in packing are shown in stick mode. (G) CSN5DC,D2–31,D232–257/CSN6DC,Da4 docking pose. The best docking pose using a
CSN5DC model in which the N- and C-terminal extensions were deleted (CSN5DC,D2–31,D232–257) is shown. Right panel: 180u rotated view of left Panel.
(H) The normalized squared displacement of the CSN5DC Ca atoms in the lowest frequency mode 7 from normal mode analysis.
doi:10.1371/journal.pone.0105688.g003
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conformationally malleable by normal mode analysis [55] of
CSN5DC, where a subset of low frequency modes shows their
propensity to undergo large-scale shear and hinge motions
(Figures 3H, S7). These secondary structure elements, stabilised
by numerous weak interactions, could be unhooked from the core
domain (Figure 3F). This analysis could strengthen the view that
CSN5DC and CSN6DC interact through an architecture reminis-
cent of the Rpn11DC/Rpn8DC complex.
The molecular architecture of the intact CSN
Finally, we wanted to interpret our CSN5DC/CSN6DC model in
the context of the full CSN complex. We adopted a hybrid
structural approach, which involved CX-MS of the intact complex
[38], cross-link-guided docking of individual subunits and domains
and molecular dynamics flexible fitting of the obtained model
using MDFF procedure in the CSN density of the previously
published CSN-SCF EM map (EMD 2173; Table S5; Figure S8)
[8,47]. For the docking we used the CSN5DC/CSN6DC model
generated in this study and for the PCI domains and missing
portions of the remaining subunits, we predicted structures using
the server Phyre [41] (Figures 4A, S8; Table S6). CSN1 and
CSN7 models were largely based on their crystal structures (PDB
codes 4LCT, 3CHM, respectively) [42,43]. The CSN5DC/
CSN6DC model described above was fitted as a rigid body
(Figure 4A) and docked in the previously assigned EM density
portion [8]. However, using our ternary complex model composed
of CSN5DC-Nedd8/CSN6DC (Figure 4A) for refinement, resulted
in a slightly different orientation. In our model, CSN6DC moved to
a more peripheral location, relative to the one previously reported
[8]. This resulted in a conspicuous density segment left empty in
the thus re-docked CSN model (Figure 4A, red star).
Multiple cross-links between the extreme C-terminal sequence
portions of peripheral and central subunits, like CSN7-CSN1 or
CSN5-CSN1 indicated that these elements contribute a major,
previously unrecognised binding interface (Table S5, Figure S8).
Importantly, most of these C-terminal elements are predicted to
adopt helical structures (Figure S8). This led us to hypothesize that
they all join in a central helical bundle in a topology reminiscent of
the 26S proteasome lid [23]. To test this hypothesis we generated
models for the C-termini of all CSN subunits and arranged them
in a compact helical bundle like in [23] (Figures 4A,B, S8). The
resulting cluster matched well the corresponding density in shape
and size (Figure 4B), although the precise orientation and topology
of the helices could not be optimized due to the low resolution of
the EM density map. Potential positions of the C-termini portions
contributing to the central bundle and of the CSN subunits were
refined to best satisfy the set of inter-subunit cross-links providing
powerful constraints (21 inter-subunits cross-links between the 8 C-
terminus subunits; Table S5).
The local cross-correlation coefficient between the revisited
CSN assembly and the EM map (ccc = 0.84) has increased
compared to the initial model (ccc = 0.80). Both models for the
eight subunits contained the same number of residues (,2,750),
but positioned differently inside the 25 A˚ resolution map, in the
particular case of CSN5/CSN6 and of the C-terminal segments.
More significantly, the average distance between lysine Cas of the
70 identified intra- and inter- cross-links is 32.9 A˚ (29.5 A˚ if 4 clear
outlier inter-subunit cross-links with distance .60 A˚ are excluded
from the analysis). This results in an improvement over the initial
model for which the average distance of the 55 cross-links was
,38 A˚, suggesting that our CX-MS guided procedure has
improved the overall subunit topology within the CSN. Illustrative
examples of the agreement between identified cross-links with the
revisited model, specifically relevant to the helical bundle and to
the CSN5/CSN6 dimer with respect to the rest of the edifice are
between the C-terminus of CSN1 and CSN3 (distance K467-
K418: 23 A˚); CSN6 and CSN7 (distance K199-K199: 27 A˚);
CSN2 and CSN5 (distance K426-K180: 22 A˚); CSN5 and CSN7
(distance K180-K199: 32 A˚). However it is noteworthy that some
of the observed cross-links linkages are difficult to reconcile with
the overall topology of the molecular model, as for example the
link between CSN1 K97 and CSN2 K415 and between CSN1
K422 and CSN3 K115. Some of these cross-links, for which the
distance in the model exceeds the maximal distance that one can
expect between two cross-linked residues, may arise from
conformational variability within parts of the CSN, as recently
demonstrated for subunits Rpn5 and Rpn6 of the 26S proteasome
lid, corresponding to CSN4 and CSN2, respectively [12,56]. It is
therefore interesting to speculate, that the observed cross-link
distribution may therefore at least partially be influenced by an
intrinsically dynamic behaviour of the CSN [8,11].
Discussion
By dissecting biochemical and structural elements of the CSN,
we have demonstrated that CSN6DC binds to the MPN domain of
the CSN5 catalytic subunit and this association increases CSN5DC
affinity for Nedd8 and enhances its hydrolytic activity on a variety
of substrates, suggesting that the MPN heterodimer could
contribute significantly to the catalytic activity of the human
CSN. The activation of an MPN+/JAMM protein mediated by a
MPN2 subunit was described in two other MPN+/JAMM-MPN2
systems, namely the 26S proteasome lid and BRCC36-containing
complexes [20,21,22]. This mechanism of activity control of
MPN+/JAMM enzymes would therefore appear to be a general
assembly and regulatory principle of the MPN+/JAMM-MPN2
containing complexes and as such would constitute an important
regulatory mechanism of these complexes [14,57].
The stimulating role of CSN6DC in CSN5DC activation
demonstrated here should be considered in the light of the data
on the CSN reported in [58]. The authors probed the function of
CSN6 and its yeast ortholog (Csi1) MPN domain in the human
and yeast CSNs, respectively. These experiments, carried out
using budding yeast and mammalian CSNs and neddylated cullins
purified from yeast and mammalian cells, concluded that only the
C-terminal part of CSN6 is necessary for the deneddylase activity.
Further investigations are needed to reconcile those results with
our observations.
Taken together, our fluorescence anisotropy binding experi-
ments and the activity measurements suggest that CSN6DC does
not contribute significantly to Nedd8 direct recruitment and
activates CSN5DC through at least two mechanisms. First, the
catalytic activity efficiency can be achieved by an increase of
affinity for Nedd8 observed either in the CSN5/CSN6 complex or
by the conformational relaxation of the Ins-1 segment. Secondly,
the increased activity can also result from a yet unknown
mechanism. Indeed, CSN5DC,WT/CSN6DC has a higher catalytic
efficiency than CSN5DC,R106T alone, although their affinity for
Nedd8 is of the same order of magnitude. The contribution of
CSN6DC to CSN5DC activation might therefore not be confined to
the enhancement of substrate binding.
Assessment of the CSN5DC/CSN6DC complex and of CSN on
different Nedd8-derived substrates provides a molecular ranking of
the catalytic activity. The higher hydrolysis rate of CSN on
neddylated Cullin1 than on Nedd8-AMC supports the observation
that CSN is a cullin deneddylase [7], underlying the contribution
of the CSN edifice in the efficient processing of neddylated CRLs.
This is therefore in agreement with the observations in [8], that
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PCI subunits contribute to the recruitment of the CRLs. Indeed
EM studies on CSN/CRL supercomplexes highlighted the direct
interaction between CSN2, and probably CSN4, and the cullin
subunit of the CRL. Taken together, these data show that the
CSN is an intricate assembly that is tailored to function on CRLs.
To further probe CSN assembly, we performed molecular
docking of the CSN5DC/CSN6DC complex guided by experimen-
tal constraints (Figure S6). The MPN domain heterodimerisation
appears to be an important aspect in the regulation of several
multiprotein complexes in eukaryotes. Vexingly, different MPN-
containing domains appear to utilise different dimerisation
Figure 4. The CSN topology. Inter-subunit cross-links between CSN5 or CSN6 Lys and other CSN subunits (Ca distances ,40 A˚) are marked with
red dotted lines. (A) The CSN assembly revisited, displayed in the EM density obtained by [8] (grey mesh). A red star indicates an unoccupied
electron density region. Close-up views of this region are shown after fitting of the helical bundle. (B) CSN5-Nedd8/CSN6 complex positioned in
the EM envelope. CSN5 is shown in orange, CSN6 in purple and Nedd8 in magenta. CSN subunits (other than CSN5 and CSN6) are shown in white
for context.
doi:10.1371/journal.pone.0105688.g004
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surfaces [14], although recent structures (budding yeast Rpn11DC/
Rpn8DC [21,22]; human CSN6DC) exhibit a dimerisation mode
consistent with the one originally described for human Rpn8DC
[50]. Interestingly our model highly resembles the crystal structure
of the Rpn11DC/Rpn8DC dimer [21,22] and the association of
CSN6DC and of Rpn8DC in the direct vicinity of the Ins-1 region of
CSN5DC and Rpn11DC, respectively, further underlines the
essential role of Ins-1 as a regulatory switch in these enzymes.
Moreover, we explored the molecular assembly of the intact
CSN by reinterpreting a published EM density map, using
molecular docking of our model of the CSN5DC/CSN6DC
complex and experimental data from CX-MS experiments. This
work provided an updated model of the CSN structure that
comprises the repositioning of the CSN5DC/CSN6DC dimer and a
central helical bundle, reminiscent of the 26S proteasome lid and
suggests that this bundle may be contributing to the assembly of
the CSN [23]. This structural analysis, complementing our work
on the MPN domains of CSN5 and CSN6 that highlights the
importance of the MPN domain interaction in the catalytic
activity, could suggest that the C-terminal regions of CSN5 and
CSN6 contribute to anchoring and optimal positioning these
subunits within the CSN assembly.
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